课题基金 / 基金详情

Characterizing Novel Components Involved in 3' End Processing of Histone pre-mRNA

Characterizing Novel Components Involved in 3' End Processing of Histone pre-mRNA
表征组蛋白前体 mRNA 3 末端加工中涉及的新成分
批准号:
7905148
负责人:
ERIC J WAGNER
金额:
$24.65万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-03 至 2012-07-31

项目摘要

项目成果

ERIC J WAGNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broad long term goals of this proposal are to study novel factors involved in the 3' end processing of histone pre-mRNA and how these factors communicate with the cell-cycle regulatory machinery. The project will be carried out in two different yet complementary model systems: Drosophila and mammalian cultured cells. Novel components required for processing of Drosophila histone pre-mRNA have recently been identified using a genome-wide dsRNA screen and this proposal is aimed at understanding the function that these new proteins play both in flies and mammals. Moreover, a novel function for a known component of this process has been recently identified as playing an essential role in the cell cycle progression. This proposal will also study the nature of this novel function and how this ties into histone pre-mRNA processing. The long term goal of the principle investigator of this research plan is to run an independent research project in a tenure-track University faculty position. This research program would involve the training of graduate students and postdoctoral fellows as well as the standard teaching requirements associated with such a position. This application is vital to the development of this career path as it includes further training from my mentor as well as a continuation of a fruitful collaborative effort with another faculty member at the University of North Carolina. Understanding the mechanisms regulating the biosynthesis of histones is essential to understand the pathology associated with Cancer. Many common chemotherapeutic anti-cancer therapies aim at inhibiting DMA synthesis. Inhibition of histone synthesis should have an equally benefical result, thus having a detailed knowledge of this pathway will increase the repetoire of drugs capable of treating this disease.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1042/bst0381082
发表时间: 2010-08
期刊: Biochemical Society transactions
影响因子: 3.9
作者: [Chen J, Wagner EJ]
通讯作者: Wagner EJ
DOI: 10.1038/nrm3274
发表时间: 2012-01-23
期刊: Nature reviews. Molecular cell biology
影响因子: --
作者: []
通讯作者:
Probing INTS11 as a novel target in neuroblastoma
  • 批准号:
    10577214
  • 项目类别:
  • 资助金额:
    $7.7万
  • 财政年份:
    2023
  • 负责人:
    ERIC J WAGNER
  • 依托单位:
Alternative Cleavage and Polyadenylation Events as Biomarkers
Alternative Cleavage and Polyadenylation Events as Biomarkers
A HTS Assay for Inhibitors of Proximal Cleavage and Polyadenylation
海外基金